Cash and investments are sufficient to fund current operations through Q2 2027, not including VenoValve commercialization and the enVVe IDE study – Cash burn of $4.2 million in Q3 remains in line with ...
The organization is urging policyholders to familiarize themselves with the warning signs of insurance fraud and report suspected schemes to insurers or law enforcement. By increasing public awareness ...